Document:

ex10_7.htm

    
      

    

    EMPLOYMENT
      AGREEMENT

     

    This
      Executive Employment Agreement, dated February 28, 2007 (the “Commencement Date”),
      is between Pools Press, Inc., an Illinois corporation (the “Company”) and Matt
      Sampson, an individual residing at ___________________________, (“Executive”).

     

    1.
      Position and Responsibilities

     

    (a)
      Position. Executive is
      employed by the Company to render services to the Company in the position of
      President.  Executive shall perform such duties and responsibilities
      as are normally related to such position in accordance with the standards of
      the
      industry and any additional duties now or hereafter assigned to Executive by
      the
      Company. Executive shall abide by the rules, regulations, and practices as
      adopted or modified from time to time in the Company’s sole
      discretion.

    

    (b)
      Other Activities. Except
      upon the prior written consent of the Company, Executive will not, during the
      term of this Agreement, (i) accept any other employment, or (ii) engage,
      directly or indirectly, in any other business activity (whether or not pursued
      for pecuniary advantage) that might interfere with Executive’s duties and
      responsibilities hereunder or create a conflict of interest with the
      Company.

    

    (c)
      No Conflict. Executive
      represents and warrants that Executive’s execution of this Agreement,
      Executive’s employment with the Company, and the performance of Executive’s
      proposed duties under this Agreement shall not violate any obligations Executive
      may have to any other employer, person or entity, including any obligations
      with
      respect to proprietary or confidential information of any other person or
      entity.

    

    (d)
      Term. The term of
      employment of Executive by the Company pursuant to this Agreement shall be
      for
      the period commencing on the Commencement Date and ending on the three year
      anniversary of the Commencement Date, or such earlier date that Employee’s
      employment is terminated in accordance with the provisions of this Agreement
      (the “Term”).

    

    2.
      Compensation and Benefits

     

    (a)
      Base Salary. In
      consideration of the services to be rendered under this Agreement, the Company
      shall pay Executive a salary at the rate of One Hundred Two Thousand Dollars
      ($102,000) per year (the “Base Salary”). The
      Base Salary shall be paid in accordance with the Company’s regularly established
      payroll practice.  Executive’s Base Salary will be reviewed from time
      to time in accordance with the established procedures of the Company for
      adjusting salaries for similarly situated employees and may be adjusted in
      the
      sole discretion of the Company.

    

    (b)
      Benefits. Executive shall
      be eligible to participate in the benefits made generally available by the
      Company to similarly-situated employees, in accordance with the benefit plans
      established by the Company, and as may be amended from time to time in the
      Company’s sole discretion.

    

    (c)
      Expenses. The Company
      shall reimburse Executive for reasonable business expenses incurred in the
      performance of Executive’s duties hereunder in accordance with the Company’s
      expense reimbursement guidelines.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    3.
      Effect of Stockholders’ Agreement

     

    (a)  As
      provided in Section 4(a)
      of the Stockholders’ Agreement of even date herewith, by and among the
Company,Derycz
      Scientific, Inc., a corporation
      organized under the laws of Nevada (“Derycz”),
      and Executive (the “Stockholders’
      Agreement”), Derycz may
      purchase Executive’s shares of the Company’s capital stock at certain dates
      before the expiration of the Term of this Agreement.  If Derycz
      exercises such option, and Executive is still employed by the Company at
      such time, Executive may either
      (i) continue his employment with the Company through the end of the Term at
      an
      increased base salary of One Hundred Thirty Five Thousand Dollars ($135,000)
      per
      year plus an amount, payable quarterly after the Company’s financial statements
      have been reviewed or audited, as applicable (the “Bonus”),
      equal to 5% of the net income, if
      any, as calculated under U.S. Generally Accepted Accounting Principles, of
      the
      Company before deduction of the Bonus; or (ii) resign from his position at
      the
      Company and collect a severance payment equal to his current Base Salary through
      the end of the term of this Agreement and will continue to be eligible to
      participate in the benefits made generally available by the Company to its
      executive staff, in accordance with the benefit plans established by the
      Company, and as may be amended from time to time in the Company’s sole
      discretion, until the end of the Term of this Agreement.

    

    (b)   As
      provided in Section 4(b) of the
      Stockholders’ Agreement, Executive may require Derycz to purchase Executive’s
      shares of the Company’s capital stock at certain dates before the expiration of
      the Term of this Agreement.  If Executive exercises such option and if
      this Agreement and/or Executive’s employment is not earlier terminated, this
      Agreement and Executive’s employment will terminate immediately upon the closing
      of such purchase without any further obligations owed by the company to
      Executive.

    

    4. At-Will
      Employment; Termination By the
      Company

    

    (a)
      At-Will Termination by the
      Company. The employment of Executive shall be “at-will” at all
      times.  The Company may terminate Executive’s employment with the
      Company at any time, without any advance notice, for any reason or no reason
      at
      all, notwithstanding anything to the contrary contained in or arising from
      any
      statements, policies or practices of the Company relating to the employment,
      discipline or termination of its employees.  Upon and after such
      termination, all obligations of the Company under this Agreement shall cease,
      unless Executive’s employment is terminated without Cause, in which case Company
      shall provide Executive with the severance benefits described in Section 4(b)
      below.

    

    (b)
      Severance.
Except in situations
      where
      the employment of Executive is terminated For Cause, By Death or By Disability
      (as defined in Section 5 below), in the event that the Company terminates the
      employment of Executive at any time, Executive will be eligible to receive
      the
      then-current Base Salary of the Executive payable in the form of salary
      continuation for the remainder of the Term.  Such Severance shall be
      reduced by any remuneration paid to Executive because of Executive’s employment
      or self-employment during the severance period, and Executive shall promptly
      report all such remuneration to the Company in writing. Executive’s eligibility
      for severance is conditioned on Executive having first signed a release
      agreement in the form attached as Exhibit A.1Executive
      shall not be entitled to any
      severance payments if Executive’s employment is terminated For Cause, By Death
      or By Disability (as defined in Section 5 below) or if Executive’s employment is
      terminated by Executive (in accordance with Section 6
      below).

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    5.
      Other Terminations By Company

     

    (a)
      Termination for Cause. For
      purposes of this Agreement, “For Cause” shall
      mean: (i) Executive commits a crime involving dishonesty, breach of trust,
      or
      physical harm to any person; (ii) Executive willfully engages in conduct that
      is
      in bad faith and materially injurious to the Company, including but not limited
      to, misappropriation of trade secrets, fraud or embezzlement; (iii) Executive
      commits a material breach of this Agreement, which breach is not cured within
      twenty (20) days after written notice to Executive from the Company; (iv)
      Executive willfully refuses to implement or follow a lawful policy or directive
      of the Company, which breach is not cured within twenty (20) days after written
      notice to Executive from the Company; or (v) Executive engages in misfeasance
      or
      malfeasance demonstrated by a pattern of failure to perform job duties
      diligently and professionally.  The Company may terminate Executive’s
      employment For Cause at any time, without any advance notice.  The
      Company shall pay to Executive all compensation to which Executive is entitled
      up through the date of termination, subject to any other rights or remedies
      of
      Employer under law; and thereafter all obligations of the Company under this
      Agreement shall cease.

     

    (b)
      By Death. Executive’s
      employment shall terminate automatically upon Executive’s death.  The
      Company shall pay to Executive’s beneficiaries or estate, as appropriate, any
      compensation then due and owing.  Thereafter all obligations of the
      Company under this Agreement shall cease.  Nothing in this Section
      shall affect any entitlement of Executive’s heirs or devisees to the benefits of
      any life insurance plan or other applicable benefits.

    

    (c)
      By Disability. If, in the
      sole opinion of the Company, Executive is unable to carry out the
      responsibilities and functions of the position held by Executive by reason
      of
      any physical or mental impairment for more than ninety (90) consecutive days
      or
      more than one hundred and twenty days (120) in any twelve-month period, then,
      to
      the extent permitted by law, the Company may terminate Executive’s
      employment.  The Company shall pay to Executive all compensation to
      which Executive is entitled up through the date of termination, and thereafter
      all obligations of the Company under this Agreement shall
      cease.  Nothing in this Section shall affect Executive’s rights under
      any disability plan in which Executive is a participant.

    

    6.
      At-Will Termination by Executive.

     

    Executive
      may terminate employment with the Company at any time for any reason or no
      reason at all, upon four weeks’ advance written notice. During such notice
      period Executive shall continue to diligently perform all of Executive’s duties
      hereunder.  The Company shall have the option, in its sole discretion,
      to make Executive’s termination effective at any time prior to the end of such
      notice period as long as the Company pays Executive all compensation to which
      Executive is entitled up through the last day of the four week notice period.
      Thereafter all obligations of the Company shall cease.

     

    7.
      Termination Obligations

     

    (a)
      Return of
      Property.  Executive agrees that all property (including
      without limitation all equipment, tangible proprietary information, documents,
      records, notes, contracts and computer-generated materials) furnished to or
      created or prepared by Executive incident to Executive’s employment belongs to
      the Company and shall be promptly returned to the Company upon termination
      of
      Executive’s employment.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    (b)
      Resignation and Cooperation.
Upon termination of Executive’s employment, Executive shall be deemed to
      have resigned from all offices and directorships then held with the Company,
      provided, however,
      that is
      Executive is still a Stockholder, as defined in the Stockholders’ Agreement, he
      may remain a director of the Company.  Following any termination of
      employment, Executive shall cooperate with the Company in the winding up of
      pending work on behalf of the Company and the orderly transfer of work to other
      employees.  Executive shall also cooperate with the Company in the
      defense of any action brought by any third party against the Company that
      relates to Executive’s employment by the Company.

    

    (c)
      Continuing Obligations.
Executive understands and agrees that Executive’s obligations under
      Sections 7, 8, and 9 herein (including Exhibits B and C) shall survive the
      termination of Executive’s employment for any reason and the termination of this
      Agreement.

    

    8.
      Inventions and Proprietary Information; Prohibition on Third Party
      Information

     

    (a)
      Proprietary Information
      Agreement. Executive agrees to sign and be bound by the terms of the
      Proprietary Information and Inventions Agreement, which is attached as Exhibit
      B
      (“Proprietary
      Information Agreement”).

    

    (b)
      Non-Solicitation.
Executive acknowledges that because of Executive’s position in the
      Company, Executive will have access to material intellectual property and
      confidential information.  During the Term of Executive’s employment
      and for one year thereafter, in addition to Executive’s other obligations
      hereunder or under the Proprietary Information Agreement, Executive shall not,
      for Executive or any third party, directly or indirectly (a) divert or attempt
      to divert from the Company any business of any kind, including without
      limitation the solicitation of or interference with any of its customers,
      clients, members, business partners or suppliers, or (b) solicit or otherwise
      induce any person employed by the Company to terminate his
      employment.

    

     (c)
      Non-Disclosure of Third
      Party Information. Executive represents and warrants and covenants that
      Executive shall not disclose to the Company, or use, or induce the Company
      to
      use, any proprietary information or trade secrets of others at any time,
      including but not limited to any proprietary information or trade secrets of
      any
      former employer, if any; and Executive acknowledges and agrees that any
      violation of this provision shall be grounds for Executive’s immediate
      termination For Cause and could subject Executive to substantial civil
      liabilities and criminal penalties.  Executive further specifically
      and expressly acknowledges that no officer or other employee or representative
      of the Company has requested or instructed Executive to disclose or use any
      such
      third party proprietary information or trade secrets.

    

    9.
      Arbitration

     

    Executive
      agrees to sign and be bound
      by the terms of the Arbitration Agreement, which is attached as Exhibit
      C.2

     

    10.
      Amendments; Waivers; Remedies

     

    This
      Agreement may not be amended or waived except by a writing approved by the Board
      of Directors and signed by Executive and by a duly authorized representative
      of
      the Company other than Executive. Failure to exercise any right under this
      Agreement shall not constitute a waiver of such right. Any waiver of any breach
      of this Agreement shall not operate as a waiver of any subsequent breaches.
      All
      rights or remedies specified for a party herein shall be cumulative and in
      addition to all other rights and remedies of the party hereunder or under
      applicable law.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    11.
      Assignment; Binding Effect

     

    (a)
      Assignment.  The
      performance of Executive is personal hereunder, and Executive agrees that
      Executive shall have no right to assign and shall not assign or purport to
      assign any rights or obligations under this Agreement.  This Agreement
      may be assigned or transferred by the Company; and nothing in this Agreement
      shall prevent the consolidation, merger or sale of the Company or a sale of
      any
      or all or substantially all of its assets.

    

    (b)
      Binding
      Effect.  Subject to the foregoing restriction on assignment by
      Executive, this Agreement shall inure to the benefit of and be binding upon
      each
      of the parties; the affiliates, officers, directors, agents, successors and
      assigns of the Company; and the heirs, devisees, spouses, legal representatives
      and successors of Executive.

    

    12.
      Notices

     

    All
      notices or other communications required or permitted hereunder shall be made
      in
      writing and shall be deemed to have been duly given if delivered:  (a)
      by hand; (b) by a nationally recognized overnight courier service; or (c) by
      United States first class registered or certified mail, return receipt
      requested, to the principal address of the other party, as set forth
      below.  The date of notice shall be deemed to be the earlier of (i)
      actual receipt of notice by any permitted means, or (ii) two (2) business days
      following dispatch by overnight delivery service or five (5) business days
      following dispatch by the United States Mail.  Executive shall be
      obligated to notify the Company in writing of any change in Executive’s
      address.  Notice of change of address shall be effective only when
      done in accordance with this paragraph.

     

    Company’s
      Notice Address:

    

    Pools
      Press, Inc.

    c/o
      Derycz Scientific, Inc.

    10990
      Wilshire Boulevard Suite 1410

    Los
      Angeles, California 90024

    Attention:  General
      Counsel

    

    Executive’s
      Notice Address:

     

    13.
      Severability

     

    If
      any
      provision of this Agreement shall be held by a court or arbitrator to be
      invalid, unenforceable, or void, such provision shall be enforced to the fullest
      extent permitted by law, and the remainder of this Agreement shall remain in
      full force and effect. In the event that the time period or scope of any
      provision is declared by a court or arbitrator of competent jurisdiction to
      exceed the maximum time period or scope that such court or arbitrator deems
      enforceable, then such court or arbitrator shall reduce the time period or
      scope
      to the maximum time period or scope permitted by law.

     

    14.
      Taxes

     

    All
      amounts paid under this Agreement (including without limitation Base Salary
      and
      Severance) shall be paid less all applicable state and federal tax withholdings
      and any other withholdings required by any applicable jurisdiction.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    15.
      Governing Law

     

    This
      Agreement shall be governed by and construed in accordance with the laws of
      the
      State of Illinois.

     

    16.
      Interpretation

     

    This
      Agreement shall be construed as a whole, according to its fair meaning, and
      not
      in favor of or against any party. Sections and section headings contained in
      this Agreement are for reference purposes only, and shall not affect in any
      manner the meaning or interpretation of this Agreement.  Whenever the
      context requires, references to the singular shall include the plural and the
      plural the singular.

     

    17.
      Obligations Survive Termination Of Employment

     

    Executive
      agrees that any and all of Executive’s obligations under this agreement,
      including but not limited to Exhibits B and C, shall survive the termination
      of
      employment and the termination of this Agreement.

     

    18.
      Counterparts

     

    This
      Agreement may be executed in any number of counterparts, each of which shall
      be
      deemed an original of this Agreement, but all of which together shall constitute
      one and the same instrument.

    

    19.
      Authority

     

    Each
      party represents and warrants that such party has the right, power and authority
      to enter into and execute this Agreement and to perform and discharge all of
      the
      obligations hereunder; and that this Agreement constitutes the valid and legally
      binding agreement and obligation of such party and is enforceable in accordance
      with its terms.

     

    20.
      Entire Agreement

     

    This
      Agreement is intended to be the final, complete, and exclusive statement of
      the
      terms of Executive’s employment by the Company and may not be contradicted by
      evidence of any prior or contemporaneous statements or agreements, except for
      agreements specifically referenced herein (including the Stockholders’ Agreement
      of even date herewith, the Executive Proprietary Information and Inventions
      Agreement attached as Exhibit B and the Arbitration Agreement attached as
      Exhibit C).  To the extent that the practices, policies or procedures
      of the Company, now or in the future, apply to Executive and are inconsistent
      with the terms of this Agreement, the provisions of this Agreement shall
      control. Any subsequent change in Executive’s duties, position, or compensation
      will not affect the validity or scope of this Agreement.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    21.
      Executive Acknowledgement

     

    EXECUTIVE
      ACKNOWLEDGES EXECUTIVE HAS HAD THE OPPORTUNITY TO CONSULT LEGAL COUNSEL
      CONCERNING THIS AGREEMENT, THAT EXECUTIVE HAS READ AND UNDERSTANDS THE
      AGREEMENT, THAT EXECUTIVE IS FULLY AWARE OF ITS LEGAL EFFECT, AND THAT EXECUTIVE
      HAS ENTERED INTO IT FREELY BASED ON EXECUTIVE’S OWN JUDGMENT AND NOT ON ANY
      REPRESENTATIONS OR PROMISES OTHER THAN THOSE CONTAINED IN THIS
      AGREEMENT.

     

    

     

    IN
      WITNESS WHEREOF, the
      parties have duly executed this Agreement as of the date first written
      above.

     

    POOLS
      PRESS, INC.

     

    By:           
      ____________________________________

    Name:

    Title:

    

    

    

    ____________________________________

    

    MATT
      SAMPSONex10_8.htm

    

      
        

      

      CAPCAS
        LICENSE
        AGREEMENT

      

      AGREEMENT
        made as of this 31th
        day of May, 2007 by and between:

      

        
          	
                   

                	
                  1.

                	
                  ELSEVIER
                    B.V., a
                    corporation organised and existing under the laws of The Netherlands,
                    with
                    offices at Radarweg 29, 1043 NX Amsterdam, The Netherlands, hereinafter
                    referred to as "LICENSOR", o f 

                
	 	 	 t
                  h
                  e   o n e   p a r t,
	 	 	 and
	 	 	 Reprints
                  Desk, a
                  corporation organised and existing under the laws of the state
                  of
                  California, US, with offices at 10990 Wilshire Boulevard, suite
                  1410, Los
                  Angeles, California 90024, USA
	 	 	 hereinafter
                  referred to as "LICENSEE",  o f   t h
                  e   o t h e r   p a r
                  t.

        

         

      

      W
        I T N E S S E T H

      
        	
                 

              	
                a)

              	
                WHEREAS,
                  LICENSOR has
                  created a database "Computer Aided Production for Current Awareness
                  Services" in electronic format, containing bibliographic information
                  and
                  abstracts of scientific articles from certain Journals owned and
                  published
                  by LICENSOR, hereinafter referred to and defined as "CAPCAS"; and
                  

              

      

      
        	
                 

              	
                b)

              	
                WHEREAS,
                  LICENSOR wishes
                  to make CAPCAS available to third parties for production purposes,
                  allowing such parties access to pre-published information from
                  the
                  Journals of LICENSOR and enabling such parties to integrate the
                  CAPCAS
                  information into the database(s) of LICENSEE said forth hereunder;
                  and
                  

              

      

      
        	
                 

              	
                c)

              	
                WHEREAS,
LICENSEE
                  is a
                  database producer and wishes to integrate CAPCAS into its current
                  Product[s], and wishes to distribute and sell these Product[s]
                  after they
                  have been integrated with CAPCAS information.

              

      

      
        	
                 

              	
                d)

              	
                WHEREAS,
                  LICENSEE wishes
                  to obtain specific rights in respect of the CAPCAS information,
                  delivered
                  by LICENSOR to LICENSEE in electronic files, as set forth hereunder;
                  

              

      

      

      NOW,
        THEREFORE, in
        consideration of the promises and agreements contained herein, the parties
        agree
        as follows:

      

      ARTICLE
        1   GRANT OF LICENCE

      1.1         
        Definitions

            
        

      
        	 	a) 	 "CAPCAS
                Data" as used in
                this Agreement, means a collection of Items, as defined
                hereunder;
	
                 

              	
                b)

              	
                "Item"
                  as used in this
                  Agreement, means the bibliographic information and abstract, when
                  included, of an individual scientific article and other document
                  types,
                  such as errata, editorials, and short communications;
                  

              

      

      
        	
                 

              	
                c)

              	
                "Journals"
                  as used in
                  this Agreement, means the Journals covered in the CAPCAS database;
                  

              

      

      
        	
                 

              	
                d)

              	
                "Multiple
                  Uses of Items"
                  as used in this Agreement, means the repeated use of an Item in
                  more than
                  one of the databases produced by the LICENSEE;

              

      

      
        	
                 

              	
                e)

              	
                "Product[s]"
                  as used in
                  this Agreement, means the Product[s] produced and published by
                  LICENSEE
                  for its Customers containing CAPCAS information;
                  

              

      

      
        	
                 

              	
                f)

              	
                "Profile"
                  as used in
                  this Agreement, means those CAPCAS Journals which are selected,
                  by
                  LICENSEE and which contain the CAPCAS Data;

              

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

      
        	
                 

              	
                g)

              	
                “Subscribed
                  Titles” as
                  used in this Agreement, means the Journal Profile obtained through
                  the
                  Licensor’s online ScienceDirect® system;

              

      

      
        	
                 

              	
                h)

              	
                "Updates"
                  as used in
                  this Agreement, means new CAPCAS Data containing the new Items
                  as
                  published in the issues of the Journals, delivered by LICENSOR
                  to LICENSEE
                  on an ongoing basis as further set forth in Article 2.1 hereunder.
                  

              

      

      

      1.2         
        Grant

      For
        the
        term of this Agreement and subject to the terms and conditions set forth
        herein,
        LICENSOR grants to LICENSEE a non-exclusive non-transferable license,
        hereinafter referred to as "the License", to do the following:

      
        	
                 

              	
                a)

              	
                To
                  mount the CAPCAS Data on the computer system of LICENSEE and to
                  extract
                  the Items from the CAPCAS Data that will be integrated with the
                  current
                  Products[s] of LICENSEE; 

              

      

      
        	
                 

              	
                b)

              	
                To
                  manipulate and to adapt the CAPCAS Data in order to conform with
                  the
                  database[s] format[s] of LICENSEE; 

              

      

      
        	
                 

              	
                c)

              	
                To
                  provide copies of the full-text articles of the Subscribed Titles
                  for the
                  sole purposes as described under this Agreement and within the
                  limitations
                  as further described in Annex 1. 

              

      

      

      
        	
                1.3

              	
                Restrictions
                  

              

      

      
        	
                 

              	
                a)

              	
                LICENSEE
                  is not allowed to reproduce, to redistribute or otherwise create
                  a
                  Product[s] copied directly and exclusively, i.e. not integrated
                  with the
                  Product[s] of LICENSEE, from the CAPCAS material provided by LICENSOR
                  to
                  LICENSEE; 

              

      

      
        	
                 

              	
                b)

              	
                LICENSEE
                  shall not grant any sublicense of any rights under this license
                  without
                  express prior written approval of LICENSOR, which approval may
                  be denied
                  for any reason; 

              

      

      
        	
                 

              	
                c)

              	
                LICENSEE
                  acknowledges the ownership and copyright of the CAPCAS information
                  of
                  LICENSOR in each Item included in the CAPCAS Data, and LICENSEE
                  agrees to
                  maintain and display LICENSOR's copyright notice which appears
                  in the
                  CAPCAS Data on each Item in all of LICENSEE's Products and Services,
                  in
                  the following form: 

              
	 	 	
                "Copyright
                   200X [relevant publication yr] Elsevier B.V... All rights reserved"
                  

              
	 	 	
                The
                  year will be changed by LICENSOR to reflect the relevant publication
                  year;
                  

              

      

      
      

      
      

      
        	
                 

              	
                d)

              	
                Except
                  for those rights specifically provided for in the License, LICENSOR
                  retains all right, title and interest in and to CAPCAS, and all
                  other
                  material and property provided by LICENSOR to LICENSEE.
                  

              

      

      

      ARTICLE
        2   SUPPLY OF CAPCAS MATERIAL

      
        	
                2.1

              	
                Updates
                  

              

      

      Subject
        to the terms and conditions set forth herein, CAPCAS shall be updated by
        LICENSOR approximately on a weekly basis.

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

      ARTICLE
        3 FEES AND
        PAYMENT

      
        	
                 

              	
                3.1

              	
                For
                  providing the CAPCAS material under this Agreement LICENSEE will
                  pay
                  LICENSOR for the content published in the period between the 1st
                  of January 2007 and the 31st
                  of December 2007 a fee of US Dollars 165,000.00 {one hundred and
                  sixty
                  five thousand}. LICENSEE will purchase the remaining 1997-2006
                  CAPCAS
                  records within 60 days of 12/31/07 latest, at a fee of $330,000.
                  

              

      

      
        	
                 

              	
                3.2

              	
                Annual
                  invoices are sent by LICENSOR to LICENSEE and are based on the
                  manner and
                  the number of Items delivered. The amount on the invoice will be
                  increased
                  with Value Added Tax ("VAT") and other taxes [where relevant].
                  Payment of
                  the invoices to LICENSOR is due within 30 days of the date set
                  forth on
                  the invoice, into a bank account designated by LICENSOR.
                  

              

      

      
        	
                 

              	
                3.3

              	
                The
                  fees set forth in article 3.1 may at the sole option of Licensor,
                  be
                  revised annually starting as from January 2008 and for each calendar
                  year.
                  Licensor will inform Licensee in writing of such a revision no
                  later than
                  October 31st
                  of each calendar year for the following calendar year. Such revisions
                  will
                  be at a reasonable level. 

              

      

      

      ARTICLE
        4  JOURNALS, CHANGES IN STRUCTURE/FORMAT

      
        	
                4.1

              	
                Journals
                  

              

      

      LICENSOR,
        in its sole discretion, may remove or add Journals to those that are covered
        by
        the CAPCAS database.

      
        	
                4.2

              	
                Changes
                  in structure/format 

              

      

      If
        and
        when LICENSOR plans to implement any significant changes in the structure
        or
        format of CAPCAS Data or other material supplied to LICENSEE, LICENSOR shall
        give written and reasonably detailed notice thereof to LICENSEE 3 [three]
        months
        in advance.

      

      ARTICLE
        5   REPRESENTATIONS AND WARRANTIES OF
        LICENSEE

      
        	
                5.1

              	
                Warranty
                  and liability 

              
	 	
                LICENSEE
                  agrees to indemnify and hold harmless, within the rules of applicable
                  law,
                  LICENSOR for any loss or liability arising from negligent acts,
                  including
                  acts of omission, and acts of wilful misconduct by LICENSEE.
                  

              

      

      
      

      

      ARTICLE
        6   REPRESENTATION AND WARRANTIES OF LICENSOR

      
        	
                6.1

              	
                Warranty
                  and liability 

              

      

      
        	
                 

              	
                a)

              	
                LICENSOR
                  hereby represents and warrants that to the best of its knowledge
                  the
                  information contained in CAPCAS does not infringe any copyright
                  of third
                  parties, but LICENSOR cannot undertake a guarantee to that effect.
                  

              

      

      
        	
                 

              	
                b)

              	
                Should
                  the CAPCAS material furnished under this Agreement become, or in
                  the
                  opinion of LICENSOR be likely to become, the subject of a claim
                  for
                  infringement, LICENSOR may authorise the continued use of, replace,
                  remove
                  or modify such CAPCAS information to render it non-infringing.
                  

              

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

      
        	
                 

              	
                c)

              	
                LICENSOR
                  DOES NOT WARRANT THE SCIENTIFIC ACCURACY OR COMPLETENESS OF THE
                  INFORMATION CONTAINED IN CAPCAS INFORMATION, NOR DOES IT WARRANT
                  THE
                  SUITABILITY OF THIS INFORMATION FOR ANY PARTICULAR USE OR APPLICATION,
                  INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTY OF MERCHANTABILITY,
                  FITNESS
                  OR SUITABILITY FOR A PARTICULAR PURPOSE. CONSEQUENTLY, LICENSOR
                  CANNOT BE
                  HELD RESPONSIBLE FOR ANY DAMAGES ARISING FROM THE USE OF CAPCAS.
                  

              

      

      
        	
                 

              	
                d)

              	
                No
                  responsibility is assumed by LICENSOR for any injury and/or damage
                  to
                  persons or property as a matter of products or services liability,
                  negligence or otherwise, or from any use or operation of any methods,
                  products, instructions or ideas contained in the CAPCAS information,
                  including lost profits, loss or use or incidental, consequential,
                  exemplary or punitive damages caused to any person as a result
                  of the use
                  of the CAPCAS material. Because of rapid advances in the medical
                  sciences,
                  independent verification of diagnoses and drug dosages should be
                  made.
                  

              

      

      
        	
                 

              	
                e)

              	
                In
                  no event will LICENSOR be liable to LICENSEE or any third party
                  for
                  consequential damages within the rules of applicable law. Where
                  liability
                  is assumed this will never exceed 25% of the annual license fee.
                  

              

      

      

      ARTICLE
        7   DURATION

      
        	
                 

              	
                7.1

              	
                This
                  Agreement shall become effective as of 1 June 2007 and shall terminate
                  on
                  31 December, 2007, hereinafter referred to as the "Termination
                  Date", with
                  an automatic renewal for subsequent 12 [twelve] months periods,
                  except if
                  either party to this Agreement gives notice in writing to the other
                  party
                  60 [sixty] days prior to the [initial] Termination Date.
                  

              

      

      

      ARTICLE
        8   CANCELLATION AND TERMINATION

      
        	
                 

              	
                8.1

              	
                Either
                  party shall be entitled to cancel this Agreement for cause by giving
                  notice in writing by registered mail to the other party, at the
                  address
                  first mentioned above, that the other party has failed to meet
                  or is
                  apparently unable or unwilling to meet one or more of the obligations
                  of
                  this Agreement. In such a case, the other party will have 60 [sixty]
                  days
                  to meet the stated obligation[s] and, if it does not do so, this
                  Agreement
                  will be cancelled effective the last day of the 60 [sixty] day
                  period, at
                  the option of the non-infringing party.

              

      

      
        	 8.2	
                Upon
                  termination or cancellation of this Agreement, all obligations
                  and rights
                  under this Agreement will end on the effective date of the termination
                  or
                  cancellation except for the payments required under this Agreement,
                  which
                  shall survive the termination or cancellation of this Agreement.
                  After
                  termination or cancellation of this Agreement, LICENSEE will abstain
                  from
                  using the original CAPCAS information supplied to it. LICENSEE
                  will erase
                  or destroy from magnetic computer tapes and disks and make unsuitable
                  for the  uses licensed under this Agreement, all original CAPCAS
                  information received from LICENSOR. An  independent third party
                  shall witness and notarise such erasure or destruction. Upon termination
                  the access  to the ScienceDirect® system shall terminate as
                  well. 

              

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

      ARTICLE
        9  ENTIRE
        AGREEMENT, AMENDMENT, NO ASSIGNMENT,  WAIVER

      
        	
                 

              	
                9.1

              	
                This
                  Agreement sets forth the entire understanding of the parties on
                  the
                  subject matter hereof, and supersedes all previous oral or written
                  representations or agreements relating to the rights and duties
                  provided
                  for herein, and this Agreement may not be modified or amended except
                  by
                  written agreement of the parties. 

              

      

      
        	
                 

              	
                9.2

              	
                If
                  the majority of shares or if a major portion of the assets of LICENSEE
                  is
                  transferred, sold, assigned or pledged to another individual or
                  company,
                  or there is a change in the control or management of LICENSEE,
                  LICENSEE
                  will notify LICENSOR in writing within 5 [five] days, and LICENSOR,
                  within
                  30 [thirty] days of the notification, will have the option of terminating
                  this Agreement upon 45 [forty five] days written notification to
                  the new
                  owner of the shares or the assets of LICENSEE, or the new controller
                  or
                  management of LICENSEE. 

              

      

      
        	
                 

              	
                9.3

              	
                This
                  Agreement shall bind and inure to the benefit of LICENSOR, its
                  successor
                  and assigns. 

              

      

      

      ARTICLE
        10  CONFIDENTIALITY AND NO AGENCY

      
        	
                10.1

              	
                The
                  parties agree to maintain as confidential and not to disclose to
                  any
                  non-affiliated third party without the other party’s prior written consent
                  the financial terms and conditions of this Agreement. 

              
	10.2  	 In
                its commercial communication LICENSEE will not make use of any trade
                name
                or trademark belonging toLICENSOR. Any reference to LICENSORS trade
                names/rights will be subject to prior approval of LICENSORwill not
                unreasonably withhold its approval	 

      

      

      ARTICLE
        11  GOVERNING LAW AND JURISDICTION

      
        	
                11.1

              	
                Governing
                  law 

              

      

      This
        Agreement shall be governed and construed in accordance with the laws of
        The
        Netherlands.

      
        	
                11.2

              	
                Jurisdiction
                  

              

      

      Any
        dispute arising in connection with this Agreement or the breach thereof,
        shall,
        in the absence of an amicable solution by the parties, belong to the exclusive
        jurisdiction of the competent courts in Amsterdam, The Netherlands.

      

      IN
        WITNESS WHEREOF, the
        parties hereto have signed this Agreement this ... day of ........,

      

      ELSEVIER
        B.V.

      

      

      

      
        	
                 

              	
                By

              	
                :

              	
                _________________________

              	
                By

              	
                :

              	
                _________________________
                  

              

      

      

      

      
        	
                 

              	
                Name

              	
                :

              	
                .........................

              	
                Name

              	
                :

              	
                Amanda
                  Spiteri 

              

      

      
        	
                 

              	
                Title

              	
                :

              	
                .........................

              	
                Title

              	
                :

              	
                Director,
                  Pharmaceutical Development Group

              

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

      

      Annex
        1

      Document
        Delivery

      

      Licensee
        is the provider of a document delivery service called [Reprints.com docdel]
        operated through [Reprints.com], through which it provides copies to its
        customers of articles from a variety of journals and periodicals through
        arrangements with the publishers of such journals and periodicals.

      

      The
        parties accept that the license provisions contained herein are more permissive
        than the provisions of local national copyright law that may apply to the
        Licensee, and agree that the provisions of this Agreement shall govern all
        aspects of the license and transactions contemplated hereby.

      

      

      Section
        1.  License and Limitations on License

      

      
        	
                1.1

              	
                Licensor
                  hereby grants a non-exclusive and non-transferable license to Licensee
                  to
                  use articles of the Subscribed Titles as source material for providing
                  document delivery services described below to its customers to
                  fulfill
                  customer requests on an article-by-article basis for specific articles
                  from the Subscribed Titles provided:

              

      

      
        	
                 

              	
                -
                  the requested article is electronically copied and electronically
                  delivered through a system with DRM technology (as described below
                  in
                  section 1.2).; and 

              

      

      
        	
                 

              	
                -
                  that no more than 3 articles from any Subscribed Title issue may
                  be
                  provided to any individual customer within a 1 month period; and
                  further
                  

              

      

      
        	
                 

              	
                -
                  that unless such information is readily apparent from the copy
                  made, the
                  source, title, author and publisher of the Subscribed Title article
                  shall
                  be included in the delivery. 

              

      

      

      
        	
                1.2.1

              	
                The
                  document delivery service will include the following technological
                  protections (as demonstrated to and approved by Licensor):
                  

              

      

      
        	
                 

              	
                -
                  an access and entitlement mechanism will be included such that
                  access will
                  be through password protected (or similar) mechanisms to ensure
                  limited
                  access; 

              

      

      
        	
                 

              	
                -
                  the electronic file can only be downloaded and saved on the requester’s
                  system twice; 

              

      

      
        	
                 

              	
                -
                  the electronic file, once downloaded, can only be printed twice;
                  and
                  

              

      

      
        	
                 

              	
                -
                  the electronic file cannot be forwarded or transmitted to other
                  parties.
                  

              

      

      

      
        	
                1.2.2

              	
                The
                  Licensee is not authorized and may not engage in systematic reproduction
                  of Elsevier Journal issues other than for the fulfillment of specific
                  requests from individual customers, is not authorized to retain
                  an archive
                  of copied requested articles, is not authorized to provide articles
                  other
                  than from Subscribed Articles and is not authorized to provide
                  print
                  deliveries under this Agreement. 

              

      

      

      
        	
                1.2.3

              	
                Neither
                  Licensee nor its customers may modify, adapt, transform, translate
                  or
                  create any derivative work based on the articles from the Elsevier
                  Journals, or otherwise use same in a manner that would infringe
                  the
                  copyright or other proprietary rights therein. Copyright notices,
                  other
                  notices or disclaimers included in the Subscribed Title articles
                  may not
                  be removed, obscured or modified in any way.

              

      

      

      Section
        2. Fees and Accounting

      

      
        	
                2.1.1

              	
                The
                  fee for the initial contract term 1 June 2007 – 31 May 2008 to be paid to
                  Licensor for each article delivered as permitted hereby shall be
                  US$30
                  based on a prepayment requirement as per 2.2 below. The rights
                  granted
                  under this license are in addition to rights that the Licensee
                  may have
                  under the copyright laws of its country to copy and deliver a certain
                  number of copies from the print Subscribed Titles.
                  

              

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

      

      Upon
        signing of this agreement Licensee shall prepay Licensor $300,000 for a maximum
        of 10,000 articles to be provided for the full year (“Credits”) multiplied by
        the fee noted above. Licensee shall pay Licensor this fee (the “Fees”) within
        thirty (30) days of date of invoice. The Fees shall be exclusive of any sales,
        use, value added, withholding or similar tax and the Licensee shall be liable
        for any such taxes in addition to the Fees.  Access to the full text
        of Subscribed Titles on ScienceDirect® will be granted by Licensor once full
        payment of the Fees has been received.

      

      Licensee
        shall provide financial statements on a quarterly basis in the format noted
        on
        Schedule 1 no later than 30 days after the close of the quarter with respect
        to
        articles from the Subscribed Titles actually delivered to customers during
        such
        period to Licensor.

      

      At
        31 May
        2008 any unused Credits shall accrue to Licensor.

      

       With
        respect to the first such quarter, the parties accept that the period shall
        commence as of the effective date hereof and end on the end of the first
        full
        quarter.

      

      
        	
                2.3

              	
                The
                  Licensee will keep records and accounts relating to the performance
                  of
                  this Agreement, in accordance with generally accepted accounting
                  practices
                  and at no cost to the Licensor. Records are not required to be
                  available
                  sooner than ninety (90) days after the due date to which they refer.
                  The
                  records must be kept intact for three (3) years, and must be available
                  at
                  the premises of the Licensee for the purpose of this Agreement,
                  for
                  inspection and the making of extracts and copies by the Licensor,
                  its
                  auditors and agents, upon reasonable written request, and at the
                  expense
                  of the Licensor, unless substantial variances of more than ten
                  (10%)
                  percent are identified and documented, in which event the Licensee
                  will
                  compensate Licensor for such expenses.

              

      

      

      Section
        3.   Proprietary, Confidential & Trade Secret
        information

      

      
        	
                3.1

              	
                In
                  order to effect this Agreement, certain information and business
                  practices
                  disclosed by the parties to each other in the course of each party’s
                  performance hereunder will be of a proprietary, confidential and
                  trade
                  secret nature (“Confidential Information”). Such Confidential Information
                  shall include, but shall not be limited to, content data, billing
                  information, software, technical protocols, service methods and
                  the terms
                  of this Agreement. The Confidential Information obligations shall
                  survive
                  the termination of this Agreement for one (1) year.
                  

              

      

      

      
        	
                3.2

              	
                Licensor
                  and Licensee hereby agree that neither party, nor any of their
                  respective
                  representatives, agents, or employees, shall use nor disclose any
                  confidential information, especially personal information, for
                  any purpose
                  other than as required and necessary for each party’s responsible
                  performance of its obligations under this Agreement, nor shall
                  either
                  party disclose any of the terms and conditions of this Agreement
                  to any
                  other party, unless so required pursuant to any administrative
                  proceeding
                  or so ordered by a court of law or other competent jurisdiction.
                  

              

      

      

      

      

      

      

      

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

      Schedule
        1 to Annex 1

      

      Format
        for periodic reports

      

      

      Period:  ____________
        through _____________, 200_.

      

      

      Sub
        Rights
        Income

      Transaction
        Import File
        Format

      

      File
        name:     Agency name, sub name
        (if any), period no. and year of return

      Format:         
        Single Header record followed by many Detail records;

      ASCII,
        column oriented (i.e. not comma
        separated/delimited);

      Character
        fields should be left
        justified;

      Numeric
        fields should be zero filled and right justified with decimal requirements
        as
        defined for individual fields

      

      
        	
                Field
                  no.

              	
                Start

              	
                Length

              	
                Item

              	
                Format

              	
                Description

              
	 	 	 	
                Header
                  Record

              	 	 
	
                1

              	
                1

              	
                1

              	
                Record
                  Type

              	
                Char

              	
                Value
                  “1”

              
	
                2

              	
                2

              	
                7

              	
                Record
                  Sequence

              	
                Numeric

              	
                “0000000”

              
	
                3

              	
                9

              	
                20

              	
                Agency
                  Name

              	
                Char

              	
                Licensee
                  name

              
	
                4

              	
                29

              	
                20

              	
                Agency
                  file reference

              	
                Char

              	
                A
                  unique identifier for this file, e.g. Agency reference, period,
                  year

              
	
                5

              	
                49

              	
                1

              	
                Constant

              	
                Char

              	
                Value
                  “A”

              
	
                6

              	
                50

              	
                8

              	
                Transaction
                  Count

              	
                Numeric

              	
                Total
                  number of Detail records

              
	
                7

              	
                58

              	
                12

              	
                Total
                  Value

              	
                Numeric

              	
                Sum
                  of the Detail record values to 2 decimal places of whole currency,
                  e.g.
                  1572.70 for $1572.70

              
	
                8

              	
                70

              	
                3

              	
                Currency

              	
                Char

              	
                ISO
                  Currency code: e.g.

                GBP
                  – Pounds Sterling,

                USD
                  – US Dollars,

                EUR
                  – Euros

              
	 	 	 	
                Detail
                  Record

              	 	 
	 	 	 	
                Mandatory
                  data

              	 	 
	
                1

              	
                1

              	
                1

              	
                Record
                  Type

              	
                Char

              	
                Value
                  “2”

              
	
                2

              	
                2

              	
                7

              	
                Record
                  Sequence

              	
                Numeric

              	
                Starting
                  at “0000001” and incrementing by 1 for each Detail
                  record

              
	
                3

              	
                9

              	
                13

              	
                Product
                  identity

              	
                Char

              	
                Valid
                  ISSN or ISBN; left justified, no separators e.g. “-“

              
	
                4

              	
                22

              	
                100

              	
                Product
                  title

              	
                Char

              	
                Journal
                  or book title

              
	
                5

              	
                122

              	
                1

              	
                Income
                  type

              	
                Char

              	
                Value
                  “C”

              
	
                6

              	
                123

              	
                3

              	
                Income
                  currency

              	
                Char

              	
                The
                  currency in which the transaction value is recorded, as per the
                  ISO
                  standard

              
	
                7

              	
                126

              	
                11

              	
                Income
                  value

              	
                Numeric

              	
                Net
                  value of the transaction to 2 decimal places (after deduction of
                  any
                  agency fees, etc.), e.g. 2.70 for $2.70

              
	 	 	 	
                Optional
                  data

              	 	 
	
                8

              	
                137

              	
                10

              	
                Invoice
                  number or transaction ref

              	
                Char

              	
                Unique
                  Agency reference for this transaction

              
	
                9

              	
                147

              	
                8

              	
                Transaction
                  date

              	
                Char

              	
                DDMMYYYY

              
	
                10

              	
                155

              	
                50

              	
                Publisher

              	
                Char

              	
                }   Free
                  format data that

              
	
                11

              	
                205

              	
                50

              	
                Author

              	
                Char

              	
                }   may
                  be available

              
	
                12

              	
                255

              	
                50

              	
                Article
                  title

              	
                Char

              	
                }   from
                  the agency to

              
	
                13

              	
                305

              	
                20

              	
                Journal
                  year

              	
                Char

              	
                }   help
                  identify any

              
	
                14

              	
                325

              	
                20

              	
                Volume
                  issue

              	
                Char

              	
                }   unrecognised
                  products.

              
	
                15

              	
                345

              	
                10

              	
                No
                  of pages

              	
                Char

              	
                }   These
                  fields should be space

              
	
                16

              	
                355

              	
                100

              	
                Any
                  other info.

              	
                Char

              	
                }   filled
                  if not available

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}]]